Kossel Medtech, which started with the production and manufacture of the balloon dilatation catheter, ushered in the major good news. Independently developed innovative medical devices, the first domestic umbrella vena cava filter Octoparms ®， after the examination and approval of China Food and Drug Administration, was approved for listing!
From 2014 to 2021, the filter went on the market for seven years. It is the first innovative product of Kossel medical. Innovation is not effortless and needs persistence. The listing of innovative products proves that Kossel’s partners have the ability for innovation. There will be more innovative products in the future.
The listing of Kossel Medtech Octoparms ® fills the market gap of domestic umbrella filter, provides a new choice for clinical treatment, opens a new stage of the application of domestic umbrella vena cava filter in the field of peripheral vascular intervention, and creates a new era of domestic original umbrella filter!